Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

OBJECTIVE To compare circulating concentrations of N terminal pro-brain natriuretic peptide (N-BNP) and cardiotrophin 1 in stable and unstable angina. DESIGN AND SETTING Observational study in a teaching hospital. PATIENTS 15 patients with unstable angina, 10 patients with stable angina, and 15 controls. MAIN OUTCOME MEASURES Resting plasma N-BNP and cardiotrophin 1 concentrations. RESULTS N-BNP concentration (median (range)) was 714 fmol/ml (177–3217 fmol/ml) in unstable angina, 169.5 fmol/ml (105.7–399.5 fmol/ml) in stable angina (p = 0.005v unstable angina), and 150.5 fmol/ml (104.7–236.9 fmol/ml) in controls (p < 0.0001v unstable angina; NSv stable angina). Cardiotrophin 1 concentration was 142.5 fmol/ml (42.2–527.4 fmol/ml) in unstable angina, 73.2 fmol/ml (41.5–102.1 fmol/ml) in stable angina (p < 0.05 v unstable angina), and 27 fmol/ml (6.9–54.1 fmol/ml) in controls (p < 0.0005v stable angina; p < 0.0001v unstable angina). Log cardiotrophin 1 correlated with log N-BNP in unstable angina (r = 0.93, p < 0.0001). CONCLUSIONS Both circulating N-BNP and cardiotrophin 1 are raised in unstable angina, while cardiotrophin 1 alone is raised in stable angina. The role of cardiotrophin 1 and the relation between cardiotrophin 1 and N-BNP in myocardial ischaemia remain to be defined.

[1]  W. Wood,et al.  Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats. , 1998, Cytokine.

[2]  H Sumida,et al.  Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. , 1996, American heart journal.

[3]  A. Rebuzzi,et al.  Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. , 1999, Circulation.

[4]  B. Brar,et al.  Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.

[5]  C. Frampton,et al.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.

[6]  D. Barnett,et al.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. , 1999, European heart journal.

[7]  S. Ogawa,et al.  Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. , 1999, Circulation research.

[8]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[9]  A. Richards,et al.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.

[10]  A. Richards,et al.  Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. , 1996, The Journal of clinical endocrinology and metabolism.

[11]  N. Tamura,et al.  Endothelin-1 and cardiotrophin-1 induce brain natriuretic peptide gene expression by distinct transcriptional mechanisms. , 1998, Journal of cardiovascular pharmacology.

[12]  K. Nakao,et al.  Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. , 1991, Canadian journal of physiology and pharmacology.

[13]  K. Chien,et al.  Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.

[14]  K. Chien,et al.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Davies,et al.  An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. , 1999, Biochemical and biophysical research communications.

[16]  I. Squire,et al.  An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. , 1999, Clinical science.

[17]  D. Barnett,et al.  Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. , 2000, European heart journal.